New owner for Chemtrix
The AGI Group has acquired Chemtrix, a Netherlands-based maker of flow reactors for industry and academia. It said that this “will bring flow chemistry scale-up capabilities into the AGI Group, supporting both pilot and manufacturing solutions”. Terms were not disclosed.
AGI is based in Japan and supplies precision manufactured glass equipment for chemical processing industries, including pharmaceuticals. It already owns Syrris, which supplies laboratory-scale flow chemistry systems, as well as the AGI Glassplant brand and Premex Reactor, a supplier of high pressure reactor systems and magnetic stirrers for R&D.
RELATED ARTICLES
UK-based speciality chemicals company Elementis has announced that, by mutual agreement, CEO Paul Waterman will step down no later than the AGM in April 2025, remaining available as required for any transition or other support until the end of July. A successor is now being sought.
Swiss CDMO Siegfried has inaugurated its new global R&D centre for drug substances at its site in Evionnaz.
International Chemical Investors Group (ICIG), the owner of WeylChem and many other European chemical assets, has acquired the European Advanced Organics business of Valtris Specialty Chemicals.
SOCMA, the trade association of the US speciality chemical manufacturing industry, has published an open letter to the pending Trump administration, urging it to “prioritise policies that encourage advancement, streamline regulatory processes and incentivise domestic manufacturing”.
BASF has formed a partnership with Slovenian white biotech Acies Bio. Under this it will further develop the latter’s OneCarbonBio fermentation platform to derive methanol for the production of fatty alcohols for home and personal care ingredients, notably surfactants.
Peptides CDMO AmbioPharm, has broken ground on a 650 m2, $28 million expansion project at its Shanghai manufacturing site. This is due to be complete in 2H 2025 and will produce over 8 tonnes/year of crude peptide.
